Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancer

Lancet. 1995 Feb 25;345(8948):525. doi: 10.1016/s0140-6736(95)90624-x.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Drug Resistance
  • Estradiol / analogs & derivatives*
  • Estradiol / therapeutic use
  • Estrogen Antagonists / therapeutic use*
  • Female
  • Fulvestrant
  • Humans
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Tamoxifen / pharmacology

Substances

  • Antineoplastic Agents
  • Estrogen Antagonists
  • Tamoxifen
  • Fulvestrant
  • Estradiol